Silibinin alleviates muscle atrophy caused by oxidative stress induced by cisplatin through ERK/FoxO and JNK/FoxO pathways
M Chi, H Zhang, Y Wang, X Sun… - … Medicine and Cellular …, 2022 - Wiley Online Library
Cisplatin (DDP), a widely used chemotherapeutic drug in cancer treatment, causes oxidative
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …
Silibinin Alleviates Muscle Atrophy Caused by Oxidative Stress Induced by Cisplatin through ERK/FoxO and JNK/FoxO Pathways
C Meng-yi, H Zhang, Y Wang, S Xi-peng… - Oxidative Medicine …, 2022 - search.proquest.com
Cisplatin (DDP), a widely used chemotherapeutic drug in cancer treatment, causes oxidative
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …
Silibinin Alleviates Muscle Atrophy Caused by Oxidative Stress Induced by Cisplatin through ERK/FoxO and JNK/FoxO Pathways
MY Chi, H Zhang, YX Wang, XP Sun… - Oxidative medicine …, 2022 - pubmed.ncbi.nlm.nih.gov
Cisplatin (DDP), a widely used chemotherapeutic drug in cancer treatment, causes oxidative
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …
[HTML][HTML] Silibinin Alleviates Muscle Atrophy Caused by Oxidative Stress Induced by Cisplatin through ERK/FoxO and JNK/FoxO Pathways
M Chi, H Zhang, Y Wang, X Sun, Q Yang… - Oxidative Medicine and …, 2022 - ncbi.nlm.nih.gov
Cisplatin (DDP), a widely used chemotherapeutic drug in cancer treatment, causes oxidative
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …
[PDF][PDF] Research Article Silibinin Alleviates Muscle Atrophy Caused by Oxidative Stress Induced by Cisplatin through ERK/FoxO and JNK/FoxO Pathways
M Chi, H Zhang, Y Wang, X Sun, Q Yang, C Guo - 2022 - scienceopen.com
Cisplatin (DDP), a widely used chemotherapeutic drug in cancer treatment, causes oxidative
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …
Silibinin Alleviates Muscle Atrophy Caused by Oxidative Stress Induced by Cisplatin through ERK/FoxO and JNK/FoxO Pathways.
MY Chi, H Zhang, YX Wang, XP Sun… - … Medicine and Cellular …, 2022 - europepmc.org
Cisplatin (DDP), a widely used chemotherapeutic drug in cancer treatment, causes oxidative
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …
stress, resulting in cancer cachexia and skeletal muscle atrophy. This study investigated the …